Trial Information

Summary: Stanford University Bipolar Disorders Clinic: Depakote ER in Bipolar Depression

Depakote has become an established treatment for the many manifestations of bipolar disorder, and preliminary data suggest that Depakote has potential efficacy in the treatment of depressive symptoms. In this study, after an initial evaluation, patients will receive Depakote ER for 8 weeks while monitored by a psychiatrist, using clinical and laboratory measures.

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:56 AM